Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere (Yttrium-90 Glass Microspheres): A HDE Treatment Use Protocol

NCT00589030 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00589030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00589030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere (Yttrium-90 Glass Microspheres): A HDE Treatment Use Protocol
Lead sponsor
City of Hope Medical Center
Phase
Expanded access
Overall status
No longer available
Start date
April 30, 2007
Completion date
September 30, 2014
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer